Apollomics (APLM) Stock Chart & Stock Price History $18.43 +6.25 (+51.34%) As of 09/25/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apollomics Stock Price Performance The Apollomics (APLM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.59%, with a year-to-date return of 89.06%. In the past month, the stock has increased 204.18%, reflecting recent market activity. As of the latest close, Apollomics traded at $18.43 with a market cap of $20.28 million and volume of 682,200 shares. Receive APLM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance+204.18%3 Month Performance+187.57%Year-To-Date Performance+89.06%1 Year Performance+38.59% APLM Stock Chart for Friday, September, 26, 2025 APLM Chart by TradingView Apollomics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/26/2025$18.43$18.43$20.98$12.16682,200 shs$20.28 million09/25/2025$18.43$18.43$20.98$12.16682,200 shs$20.28 million09/24/2025$18.43$18.43$20.98$12.16682,200 shs$20.33 million09/23/2025$18.43$18.43$20.98$12.16682,200 shs$20.28 million09/22/2025$18.43$18.43$20.98$12.16682,200 shs$20.28 million09/19/2025$18.67$18.43-1.27%$20.98$12.16682,200 shs$20.28 million09/18/2025$18.67$18.67$20.98$12.16682,200 shs$20.59 million09/17/2025$12.18$18.67+53.28%$20.98$12.16682,277 shs$20.54 million09/16/2025$9.29$12.18+31.11%$12.50$9.00170,777 shs$13.40 million09/15/2025$6.83$9.29+36.02%$9.95$6.94232,068 shs$10.25 million Get the Latest News and Ratings for APLM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. 09/12/2025$6.14$6.83+11.33%$7.00$6.2736,420 shs$7.53 million09/11/2025$6.19$6.14-0.89%$6.40$5.9724,602 shs$6.75 million09/10/2025$5.89$6.19+5.18%$6.25$5.757,531 shs$6.81 million09/09/2025$5.51$5.89+6.90%$6.20$5.6144,573 shs$6.49 million09/08/2025$5.17$5.51+6.46%$5.87$5.2028,886 shs$6.06 million09/05/2025$5.48$5.17-5.64%$5.75$5.0838,528 shs$5.69 million09/04/2025$4.19$5.48+30.94%$5.70$4.21205,731 shs$6.03 million09/03/2025$4.21$4.19-0.59%$4.54$3.9533,855 shs$4.60 million09/02/2025$3.93$4.21+7.12%$4.29$3.9411,815 shs$4.63 million09/01/2025$3.93$3.93$4.21$3.6681,762 shs$4.32 million08/29/2025$4.18$3.93-5.98%$4.21$3.6681,762 shs$4.32 million08/28/2025$6.23$4.18-32.91%$5.27$4.06132,367 shs$4.60 million08/27/2025$6.06$6.23+2.81%$6.37$6.162,852 shs$6.87 million08/26/2025$6.33$6.06-4.27%$6.20$5.962,604 shs$6.67 million08/25/2025$6.31$6.33+0.40%$6.33$5.764,633 shs$6.96 million Related Companies CervoMed Stock Chart Acumen Pharmaceuticals Stock Chart Repare Therapeutics Stock Chart PMV Pharmaceuticals Stock Chart vTv Therapeutics Stock Chart Unicycive Therapeutics Stock Chart OS Therapies Stock Chart Sutro Biopharma Stock Chart Quantum Biopharma Stock Chart Eliem Therapeutics Stock Chart Receive APLM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APLM) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqOn September 30, 2025, at midnight ET... a groundbreaking emergency order goes into effect, issued directly by...Altimetry | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondMost “hot AI stocks” will vanish — but Weiss Ratings’ system, ranked #1 for accuracy, just flagged 10 AI stock...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
